Echocardiographic Features and Long-term Follow Up of Fabry Disease at Mayo Clinic

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 17-002116
    Sponsor Protocol Number: 17-002116

About this study

This study will describe the echocardiographic features and long-term clinical outcomes among patients with Fabry disease seen at Mayo Clinic

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion:

All adult patients (age > 18) seen at Mayo Clinic who underwent a TTE and had a confirmed diagnosis of Fabry disease confirmed by laboratory or genetic analysis or direct tissue inspection will be eligible for inclusion.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Darrell Newman, M.D.

Contact us for the latest status

Contact information:

Darrell Newman M.D.

Newman.Darrell@mayo.edu